Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is a common neurodegenerative disorder thought to be associated with mitochondrial dysfunction. Loss of function mutations in the putative mitochondrial protein PINK1 (PTEN-induced kinase 1) have been linked to familial forms of PD, but the relation of PINK1 to mammalian mitochondrial function remains unclear. Here, we report that germline deletion of the PINK1 gene in mice significantly impairs mitochondrial functions. Quantitative electron microscopic studies of the striatum in PINK1 −/− mice at 3–4 and 24 months revealed no gross changes in the ultrastructure or the total number of mitochondria, although the number of larger mitochondria is selectively increased. Functional assays showed impaired mitochondrial respiration in the striatum but not in the cerebral cortex at 3–4 months of age, suggesting specificity of this defect for dopaminergic circuitry. Aconitase activity associated with the Krebs cycle is also reduced in the striatum of PINK1 −/− mice. Interestingly, mitochondrial respiration activities in the cerebral cortex are decreased in PINK1 −/− mice at 2 years compared with control mice, indicating that aging can exacerbate mitochondrial dysfunction in these mice. Furthermore, mitochondrial respiration defects can be induced in the cerebral cortex of PINK1 −/− mice by cellular stress, such as exposure to H 2 O 2 or mild heat shock. Together, our findings demonstrate that mammalian PINK1 is important for mitochondrial function and provides critical protection against both intrinsic and environmental stress, suggesting a pathogenic mechanism by which loss of PINK1 may lead to nigrostriatal degeneration in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, when PINK1 is mutated, it loses its function, which means there is no longer any protection against ROS [141].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [141]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, mitophagy deficiency favored by ablation of Prkn (Palacino et al, 2004; Pickrell et al, 2015) or Pink1 (Gautier et al, 2008) sensitizes mice to oxidative stress, while worsening neural damage when combined with mitochondrial dysfunction (mitochondrial DNA [mtDNA] mutator‐prkn/parkin‐KO mice) (Pickrell et al, 2015).”
From Autophagy in major human diseases (2021) · cites this paper as Gautier et al, 2008
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 1×
“The recent discovery of recessively inherited loss of function mutations in three distinct genes that are linked to early onset parkinsonism (7–9) has provided a unique opportunity to create in vivo models to identify early pathogenic changes, which may ultimately lead to neurodegeneration (10).”
Self-citationChronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683 · cited 1×
“Accidental exposure to mitochondrial toxins leads to symptoms resembling those of PD via the selective death of dopaminergic neuron (5, 6).”
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481 · cited 1×
“Bioinformatics analysis reveals that PINK1 is a putative serine-threonine kinase with a mitochondrial targeting motif at its N-terminal end (9).”
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053 · cited 1×
“A growing number of clinical and experimental reports implicate mitochondrial dysfunctions and oxidative stress in the pathogenesis of PD (1, 2).”
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · cited 2×
“In fact, two recent articles showed dramatic functional and structural impairments of mitochondria in Drosophila bearing null mutations for dPINK1 (14, 15).”
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705 · cited 3×
“In fact, two recent articles showed dramatic functional and structural impairments of mitochondria in Drosophila bearing null mutations for dPINK1 (14, 15).”
Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401135200 · Cited by 995
Self-citationThe PINK1/Parkin pathway regulates mitochondrial morphology
Poole, A. C., Thomas, R. E., Andrews, L. A., McBride, H. M., Whitworth, A. J., & Pallanck, L. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709336105 · Cited by 885 · cited 2×
“How can one explain such a protective role of PINK1 in mitochondria? One possibility, raised by studies in flies, is that PINK1 is involved in the regulation of mitochondrial fission and fusion (16, 17).”
Cited by
Items 401–500 of 722
Akundi, R. S., Zhi, L., Sullivan, P. G., & Büeler, H. (2012) · Neurodegenerative Diseases · doi:10.1159/000345689 · Cited by 28
Mouse models of Parkinson's disease associated with mitochondrial dysfunction
Pickrell, A. M., Pinto, M., & Moraes, C. T. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.08.002 · Cited by 28
Gene therapy: a viable therapeutic strategy for Parkinson’s disease?
Berry, A. L., & Foltynie, T. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5796-9 · Cited by 28
“Animal models indicate pathogenic mitochondrial enlargement, disintegration and superoxide oxidative stress [100, 101].”
BackgroundJohnson, R. A., Kelm‐Nelson, C. A., & Ciucci, M. R. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-191853 · Cited by 33
“The Pink1 gene is hypothesized to protect cells during stress-induced mitochondrial dysfunction [35].”
Potential Role of Mic60/Mitofilin in Parkinson’s Disease
Laar, V. S. V., Otero, P. A., Hastings, T. G., & Berman, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00898 · Cited by 27
“Until 2007 PINK1 had only been associated with mitochondrial oxidative stress and dysfunction (Exner et al., 2007; Gautier et al., 2008; Weihofen et al., 2008).”
BackgroundHartman, J. H., González-Hunt, C. P., Hall, S. M., Ryde, I. T., Caldwell, K. A., Caldwell, G. A., & Meyer, J. N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133202 · Cited by 28
“Loss of pink-1 in mice [52] and worms [26] caused impairment of mitochondrial respiration.”
BackgroundHa, J., Kim, J., Kim, S.-E., & Son, J. H. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2013.12.064 · Cited by 26
Molecular Mechanisms of PINK1-Related Neurodegeneration
Pogson, J. H., Ivatt, R. M., & Whitworth, A. J. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0187-x · Cited by 30
Immune cell metabolic dysfunction in Parkinson’s disease
Mark, J. R., & Tansey, M. G. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00827-y · Cited by 26
“Meanwhile, PINK1 KO and chronic MPTP treatment in aged mice have been shown to significantly reduce the maximal respiratory rate of mitochondria from the striatum [62, 63].”
The mitochondrial kinase PINK1, stress response and Parkinson’s disease
Jendrach, M., Gispert, S., Ricciardi, F., Klinkenberg, M., Schemm, R., & Auburger, G. W. J. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9256-0 · Cited by 29
“…PINK1deficient cells (Clark et al. 2006; Gautier et al. 2008; Haque et al. 2008; Jendrach, unpublished data), murine models in contrast to D. melanogaster show no discernible signs of apoptosis in the unstressed state (Park et al. 2006; Clark et al. 2006; Gautier et al. 2008; Gispert et al. 2009).”
BackgroundResultInfluentialProtein degradation in Parkinson disease revisited: it’s complex
Li, H., & Guo, M. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38619 · Cited by 28
Khan, N., Pelletier, D., McAlear, T. S., Croteau, N., Veyron, S., Bayne, A. N., Black, C., Ichikawa, M., Khalifa, A. A. Z., Chaaban, S., et al. (2021) · Structure · doi:10.1016/j.str.2021.01.001 · Cited by 24
Sun, Y., Pham, A. N., Hider, R. C., Zheng, H., & Waite, T. D. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00557 · Cited by 24
Naoi, M., Maruyama, W., Shamoto‐Nagai, M., & Riederer, P. F. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-023-02730-6 · Cited by 24
“PINK1 deletion in mice increased numbers of larger mitochondria in the striatum, defects in complex I, and increased sensitivity to oxidative stress (Gautier et al. 2008).”
A novel PGC-1α isoform in brain localizes to mitochondria and associates with PINK1 and VDAC
Choi, J., Batchu, V. V. K., Schubert, M., Castellani, R. J., & Russell, J. W. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.041 · Cited by 24
Zhou, B. O., Wen, M., Lin, X., Chen, Y., Gou, Y., Li, Y., Zhang, Y., Li, H.-W., & Tang, L. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9819-5 · Cited by 26
Kelm‐Nelson, C. A., & Gammie, S. C. (2020) · BMC Genomics · doi:10.1186/s12864-020-07037-4 · Cited by 32
The Pathopharmacological Interplay between Vanadium and Iron in Parkinson’s Disease Models
Ohiomokhare, S., Olaolorun, F., Ladagu, A. D., Olopade, F. E., Howes, M. R., Okello, E. J., Olopade, J. O., & Chazot, P. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186719 · Cited by 25
“T e loss of PINK-1 causes an inhibition/red ction of the mitochondrial respiratory capacity, with Complexes I and II being th most affected [40].”
BackgroundAnimal Models of Parkinson’s Disease
Blesa, J., Trigo‐Damas, I., Quiroga‐Varela, A., & del Rey, N. L. (2016) · InTech eBooks · doi:10.5772/63328 · Cited by 31
Lee, D., Lee, K., Um, J., Kim, Y.-Y., Kim, D., & Yun, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216542 · Cited by 23
“To test this possibility, we examined the effect of palmatine treatment on PINK1 knockout (PINK1 KO) MEFs, a well-known mitochondrial dysfunction model accompanying various phenotypes, such as an increase in mitochondrial ROS and a decrease in the respiration rate [24,25].”
BackgroundExistence of Pink1 Antisense RNAs in Mouse and Their Localization
Chiba, M., Kiyosawa, H., Hiraiwa, N., Ohkohchi, N., & Yasue, H. (2009) · Cytogenetic and Genome Research · doi:10.1159/000251963 · Cited by 23
“…Accessible online at: www.karger.com/cgr Chiba /Kiyosawa /Hiraiwa /Ohkohchi / Yasue Cytogenet Genome Res 2009;126:259–270 260 and knockout mice have been developed as a model of PD in human [Zhou et al., 2007; Gautier et al., 2008; Terzioglu and Galter, 2008; Morais et al., 2009].”
Hirabayashi, T., Nakanishi, R., Tanaka, M., Nisa, B. U., Maeshige, N., Kondo, H., & Fujino, H. (2021) · Physiological Reports · doi:10.14814/phy2.14763 · Cited by 23
“Moreover, previous studies showed that PGC1α and PINK1 affect mitochondrial metabolic capacity in the skeletal muscle (Gautier et al., 2008; Zechner et al., 2010).”
BackgroundThe intertwined relationship between circadian dysfunction and Parkinson's disease
Duret, L. C., & Nagoshi, E. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.10.006 · Cited by 22
Wu, Z., Li, Y.-C., Zheng, Y., Zhou, M., Li, H. Z., Wu, S.-X., Zhao, X., Yang, Y., & Du, L. (2025) · Food & Function · doi:10.1039/d4fo04341c · Cited by 22
Mitochondrial proteotoxicity: implications and ubiquitin-dependent quality control mechanisms
Karbowski, M., Oshima, Y., & Verhoeven, N. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04604-8 · Cited by 23
“In healthy active mitochondria, PINK1 localizes to the mitochondrial matrix and likely controls mitochondrial respiration [161].”
BackgroundMitochondria: Prospective Targets for Neuroprotection in Parkinson’s Disease
Yadav, A., Agarwal, S., Tiwari, S. K., & Chaturvedi, R. K. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140305224545 · Cited by 23
Mechanisms of neurodegeneration in Parkinson’s disease: keep neurons in the PINK1
Brunelli, F., Valente, E. M., & Arena, G. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111277 · Cited by 23
Brain Damage - Bridging Between Basic Research and Clinics
González-Quevedo, A. (2012) · InTech eBooks · doi:10.5772/2174 · Cited by 22
Han, Y., Zhuang, N., & Wang, T. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108875 · Cited by 26
PINK1 activation–turning on a promiscuous kinase
Aerts, L., Strooper, B. D., & Morais, V. A. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150002 · Cited by 22
Mitochondrial Homeostasis Molecules: Regulation by a Trio of Recessive Parkinson’s Disease Genes
Han, J., Kim, J., & Son, J. H. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.4.345 · Cited by 23
“For example, mitochondrial impairments are observed in patients carrying PINK1 mutations [7] and PINK1null mice [8], PINK1-null fruit flies [9, 10] and a PINK1-null dopaminergic neuron model [11].”
BackgroundOxidative stress alters the regulatory control of p66Shc and Akt in PINK1 deficient cells
Maj, M. C., Tkachyova, I., Patel, P., Addis, J., MacKay, N., Levandovskiy, V., Lee, J., Lang, A. E., Cameron, J. M., & Robinson, B. H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.033 · Cited by 21
Aging and energetics’ ‘Top 40’ future research opportunities 2010-2013
Allison, D. B., Antoine, L. H., Ballinger, S. W., Bamman, M. M., Biga, P. R., Darley-Usmar, V. M., Fisher, G., Gohlke, J. M., Halade, G. V., Hartman, J. L., et al. (2014) · F1000Research · doi:10.12688/f1000research.5212.1 · Cited by 23
Śmieszek, A., Marcinkowska, K. A., Pielok, A., Sikora, M., Valihrach, L., Carnevale, E. M., & Marycz, K. (2022) · Cells · doi:10.3390/cells11091437 · Cited by 22
Early diagnosis and therapy of Parkinson’s disease: can disease progression be curbed?
Kansara, S. G., Trivedi, A., Chen, S., Jankovic, J. J., & Le, W. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0840-9 · Cited by 22
“2004), plays a neuroprotective role in mitochondria; PINK1-deficient mice demonstrate reduced long-term viability and mitochondrial dysfunction mediated by oxidative stress (Gautier et al. 2008).”
BackgroundSeita, Y., Tsukiyama, T., Azami, T., KOBAYASHI, K. P., Iwatani, C., Tsuchiya, H., Nakaya, M., Tanabe, H., Hitoshi, S., Miyoshi, H., et al. (2019) · Biology of Reproduction · doi:10.1093/biolre/ioz040 · Cited by 21
Parkinson’s disease: what the model systems have taught us so far
Ghatak, S., Trudler, D., Dolatabadi, N., & Ambasudhan, R. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0960-6 · Cited by 23
Guo, M., & Buch, S. J. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146446 · Cited by 20
“For example, Pink1 knockout mice demonstrated age-dependent impairment of mitochondrial respiration and increased numbers of larger mitochondria in the cortex [60].”
BackgroundMaynard, M. E., Redell, J. B., Kobori, N., Underwood, E. L., Fischer, T. D., Hood, K. N., LaRoche, V., Waxham, M. N., Moore, A. N., & Dash, P. K. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113081 · Cited by 21
“It has been previously reported that mitochondria in the striatum are morphologically normal in either adult (3–4 month) or aged (22–24 month) Pink1−/− mice, with an increase in the number of longer mitochondria (Gautier et al., 2008).”
BackgroundResultKelm‐Nelson, C. A., Stevenson, S. A., & Ciucci, M. R. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.003 · Cited by 26
Control of mitochondrial integrity in Parkinson’s disease
Vives-Bauzá, C., Tocilescu, M. A., deVries, R. L. A., Wolken, D. M. A., Jackson-Lewis, V. R., & Przedborski, S. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)83006-7 · Cited by 20
García‐Beltrán, O., Urrutia, P. J., & Núñez, M. T. (2023) · Antioxidants · doi:10.3390/antiox12020214 · Cited by 23
OXPHOS toxicogenomics and Parkinson's disease
López‐Gallardo, E., Iceta, R., Iglesias, E., Montoya, J., & Ruiz‐Pesini, E. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.06.004 · Cited by 25
PINK1 Silencing Modifies Dendritic Spine Dynamics of Mouse Hippocampal Neurons
Hernandez, C., Báez-Becerra, C. T., Contreras-Zarate, M. J., Arboleda, H., & Arboleda, G. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01385-x · Cited by 19
Miller, D. L., Hannon, C. E., & Ganetzky, B. (2012) · Journal of Neurogenetics · doi:10.3109/01677063.2012.706346 · Cited by 22
“…and the mitochondrial machinery are emerging as prominent players in human neurodegenerative diseases (Valente et al., 2004; Manfredi & Xu, 2005; Gautier et al., 2008; Narendra et al., 2008; Magrane & Manfredi, 2009; Shi et al., 2009; Du et al., 2010; Narendra et al., 2010; Dupuis et al., 2011;…”
BackgroundParkinson’s disease research: adopting a more human perspective to accelerate advances
Marshall, L. J., & Willett, C. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.09.010 · Cited by 19
Bridging pathway dysfunction and therapy: novel compounds for neuroprotection
Patel, S., Prajapati, C., Nand, S., & Singh, S. K. (2026) · 3 Biotech · doi:10.1007/s13205-026-04697-z · Cited by 20
Okyere, S. K., Zeng, C., Dong, Y., & Hu, Y. (2020) · Venoms and Toxins · doi:10.2174/2666121701999201104163407 · Cited by 21
Cardiovascular aging: the mitochondrial influence
Sagar, S., & Gustafsson, Å. B. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.22 · Cited by 19
“Also, PINK1 deficient mice exhibit accelerated decline in mitochondrial function and accumulation of megamitochondria in the cortex[79].”
BackgroundSimcox, E. M., Reeve, A. K., & Turnbull, D. M. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130189 · Cited by 20
NIP/DuoxA is essential for Drosophila embryonic development and regulates oxidative stress response
Xie, X., Hu, J., Liu, X., Qin, H., Percival‐Smith, A., Rao, Y., & Li, S. S. ‐. (2010) · International Journal of Biological Sciences · doi:10.7150/ijbs.6.252 · Cited by 21
“This reduction in mitochondrial function may underlie the compromised ability of the nip-RNAi flies to survive under cellular stress such as exposure to oxidative compounds or mild heat shock [21].”
BackgroundWang, D., Zhang, D., Feng, J., Li, G.-D., Li, X.-A., Yu, X.-F., Long, H., Li, Y., & Yao, Y. (2016) · Scientific Reports · doi:10.1038/srep37086 · Cited by 18
Warnsmann, V., Marschall, L., & Osiewacz, H. D. (2021) · Cells · doi:10.3390/cells10040757 · Cited by 19
Prematurity alters the progenitor cell program of the upper respiratory tract of neonates
Shui, J. E., Wang, W., Liu, H., Степанова, А., Liao, G., Qian, J., Ai, X., Ten, V. S., Lü, J., & Cardoso, W. V. (2021) · Scientific Reports · doi:10.1038/s41598-021-90093-x · Cited by 18
Iron, Oxidative Stress and Health
Udipi, S., Ghugre, P., & Gokhale, C. (2012) · Oxidative Stress - Molecular Mechanisms and Biological Effects · doi:10.5772/34975 · Cited by 17
Iron-sulfur cluster loss in mitochondrial CISD1 mediates PINK1 loss-of-function phenotypes
Bitar, S., Baumann, T., Weber, C., Abusaada, M., Rojas-Charry, L., Ziegler, P., Schettgen, T., Randerath, I. E., Venkataramani, V., Michalke, B., et al. (2024) · eLife · doi:10.7554/elife.97027 · Cited by 17
Madeo, G., Schirinzi, T., Maltese, M., Martella, G., Rapino, C., Fezza, F., Mastrangelo, N., Bonsi, P., Maccarrone, M., & Pisani, A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.021 · Cited by 18
Heales, S., Menzes, A., & Davey, G. P. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.032 · Cited by 18
“Reduced complex I activities in mitochondria from Parkin and PINK1 knockout animals [49,50] as well as in leukocytes from patients with parkin mutations have been identified [51], although interestingly, in parkin/DJ1/PINK1 triple knockout mice no such deficiencies are present [52].”
BackgroundYuan, X.-L., Guo, J., Shi, Z., Zhi-qian, X., Yan, X., Zhao, B., & Tang, B. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.005 · Cited by 19
“…stress-induced death and PINK1dificient cells were more susceptible to apoptosis when exposure to mitochondrial toxins (Valente et al., 2004; Bonifati et al., 2005; Silvestri et al., 2005; Deng et al., 2005; Gandhi et al., 2006; Gautier et al., 2008; Wood-Kaczmar et al., 2008; Morais et al., 2009).”
PINK1 in mitochondrial function
Plun‐Favreau, H., & Hardy, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805908105 · Cited by 17
“In the present study (7), defects in complex I and also in complexes II–IV were observed in the striatum of the PINK1 / mice.”
BackgroundInfluentialBraczynski, A. K., Vlaho, S., Müller, K., Wittig, I., Blank, A., Tews, D. S., Drott, U., Kleinle, S., Abicht, A., Horváth, R., et al. (2015) · BioMed Research International · doi:10.1155/2015/462592 · Cited by 18
Kim, Y. Y., Yoon, J.-H., Um, J., Jeong, D. J., Shin, D. J., Hong, Y. B., Kim, J. K., Kim, D. H., Kim, C., Chung, C. G., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239126 · Cited by 17
“In contrast, the loss of PINK1 resulted in severe mitochondrial dysfunction in a Drosophila model [16], a cell line [28] and a mouse model [46].”
BackgroundGaramszegi, S. P., Banack, S. A., Duque, L., Metcalf, J. S., Stommel, E. W., Cox, P. A., & Davis, D. A. (2023) · Toxicology Reports · doi:10.1016/j.toxrep.2023.01.002 · Cited by 17
Differential regulation of NMDA receptor function by DJ‐1 and PINK1
Chang, N., Li, L., Hu, R., Shan, Y., Liu, B., Li, L., Wang, H., Feng, H., Wang, D., Cheung, C. C., et al. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00615.x · Cited by 18
“…dopaminergic neurons (Wang et al., 2006), and that the loss of PINK1 leads to functional defects of mitochondria, causes mitochondrial calcium overload, increased sensitivity to oxidative stress, reduced dopamine release and impaired synaptic plasticity (Kitada et al., 2007; Gautier et al., 2008).”
BackgroundKim, K., & Yim, J. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.07.011 · Cited by 16
“Consistent with these findings in Drosophila, animals with parkin or PINK1 mutations also show mitochondrial defects [22,23].”
ResultPropofol-induced hippocampal Neurotoxicity: A mitochondrial perspective
Ebrahimi, M., Dabbagh, A., & Madadi, F. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148841 · Cited by 15
The Mitochondrial Foundations of Parkinson’s Disease: Therapeutic Implications
Soman, S. K., Woodruff, M. R. J., & Dagda, R. K. (2025) · Aging and Disease · doi:10.14336/ad.2025.0440 · Cited by 23
“Similarly, a decrease in aconitase activity was observed, suggesting a deficiency in the TCA cycle as well [187].”
Moon, J. H., Kim, J. H., Im, H., Lee, D. S., Park, E., Song, K., Oh, H. J., Hyun, S. B., Kang, S. C., Kim, H., et al. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.3.258 · Cited by 15
“kinase 2 (LRRK2) [17], autosomal dominant PD, PTEN-induced putative kinase 1 (PINK1) [18], Parkin [19] and DJ-1 [20], autosomal recessive PD.”
BackgroundInfluentialNeuroprotection in Parkinson's Disease: a Realistic Goal?
Galati, S., & Giovanni, G. D. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00206.x · Cited by 15
“On the other hand, genetic alterations leading to abnormal protein aggregation, or excessive oxidative stress, or alteration of apoptotic mechanisms account for the less common familial cases [9–11].”
Differential roles of GluN2A- and GluN2B-containing NMDA receptors in neuronal survival and death.
Lujan, B., Liu, X., & Wan, Q. (2012) · PubMed · Cited by 27
In a flurry of PINK, mitochondrial bioenergetics takes a leading role in Parkinson's disease
Murphy, A. N. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900020 · Cited by 17
Mitochondrial Regulation by PINK1-Parkin Signaling
Imai, Y. (2012) · ISRN Cell Biology · doi:10.5402/2012/926160 · Cited by 17
Zhu, Y., Aredo, B., Chen, B., Zhao, C. X., He, Y.-G., & Ufret-Vincenty, R. L. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-27212 · Cited by 16
“develop an increased number and/or size of mitochondria in RPE cells, which seems to correlate with dysfunction.(34,49,50) In”
Aging, Parkinson’s Disease, and Models: What Are the Challenges?
Bellantuono, I., Mortiboys, H., Rocha, E. M., Chamoli, M., Chinta, S. J., Andersen, J. K., Wallis, R., Bézard, E., Goldberg, M., Greenamyre, T., et al. (2023) · doi:10.59368/agingbio.20230010 · Cited by 16
“It is possible that the shortened lifespan of mice in comparison to humans can explain the absence of profound SN DA neurodegeneration; investigation of cellular mechanisms in these mice well before death may contribute to our knowledge of the mechanisms leading to early-onset PD in humans.”
BackgroundGenetic Mutations and Mitochondrial Toxins Shed New Light on the Pathogenesis of Parkinson's Disease
Sato, S., & Hattori, N. (2011) · Parkinson s Disease · doi:10.4061/2011/979231 · Cited by 14
“Impaired mitochondrial respiration was observed in the brain of PINK1 null mice [65] although the mechanism linking PINK1 to mitochondrial membrane potential remains to be determined.”
BackgroundGonçalves, D. F., Duarte, T., Foletto, J. V. P., Senger, L. R., Barbosa, N. V., Soares, F. A. A., & Corte, C. L. D. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.06.007 · Cited by 14
Zekri-Nechar, K., Zamorano‐León, J. J., Cortina-Gredilla, M., López‐de‐Andrés, A., Jiménez‐García, R., Cuéllar, C. N., López-Farré, A. J., & Martínez-Martínez, C. H. (2022) · Diabetes and Vascular Disease Research · doi:10.1177/14791641221129877 · Cited by 14
“Interestingly, studies in Pink-1 / cells have suggested that changes in Pink-1 expression could be enough to control mitophagy and ROS production.(11) In this line of evidence, reduction of ΔΨm has been closely associated with decreased mitochondria function and elevated ROS production,(12) being observed in the prese…”
ResultKim, J. J., Daadi, E. W., Oh, T. T., Daadi, E. S., & Daadi, M. M. (2022) · Genes · doi:10.3390/genes13111937 · Cited by 14
“PINK1 knockout mice appear to have an age-dependent and moderate reduction in striatal dopamine levels accompanied by low locomotor activity due to deficient mitochondrial respiration and increased sensitivity to oxidative stress [352,353].”
BackgroundZhang, L., Dai, Z., Shi, S., Yan, Z., Yang, J., Xue, W., He, Y., Mi, S., Cheng, C., Wang, L., et al. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116168 · Cited by 13
CHCHD2 mutant mice link mitochondrial deficits to PD pathophysiology
Liao, S.-C., Kano, K., Phanse, S., Nguyen, M. K., Margolis, E. B., Fu, Y., Meng, J. X., Moutaoufik, M. T., Chatterton, Z., Saccon, T. D., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu0726 · Cited by 13
Animal Models of Autosomal Recessive Parkinsonism
Bastioli, G., Regoni, M., Cazzaniga, F. A., Luca, C. M. G. D., Bistaffa, E., Zanetti, L., Moda, F., Valtorta, F., & Sassone, J. (2021) · Biomedicines · doi:10.3390/biomedicines9070812 · Cited by 13
Kitada, T., Ardah, M. T., & Haque, M. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316734 · Cited by 17
“Previously, reduced mitochondrial respiratory capacity, increased mitochondrial calcium ions, and oxidative stress in the PINK1 -deficient mouse brains, as well as increased oxidative stress in the cytoplasm, have been observed [35].”
BackgroundSelf-citationHepatic Mitochondrial Dysfunction and Risk of Liver Disease in an Ovine Model of “PCOS Males”
Siemienowicz, K. J., Filis, P., Thomas, J. L., Fowler, P., Duncan, W. C., & Rae, M. T. (2022) · Biomedicines · doi:10.3390/biomedicines10061291 · Cited by 14
“The loss of PINK1 results in mitochondrial dysfunction, decreased OXPHOS, and increased sensitivity to oxidative stress [97,98].”
BackgroundQin, X., Zheng, C., Yates, J. R., & Liao, L. (2014) · Molecular BioSystems · doi:10.1039/c3mb70565j · Cited by 13
Unravelling the role of defective genes
Cookson, M. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)83003-1 · Cited by 14
“Further more, while mice deficient in parkin or PINK1 do not have dramatic phenotypes, they do have impair ment of mitochondrial function (Gautier et al., 2008; Palacino et al., 2004).”
Tackling neurodegenerative diseases: animal models of Alzheimer’s disease and Parkinson’s disease
Raslan, A., & Kee, Y. (2013) · Genes & Genomics · doi:10.1007/s13258-013-0116-2 · Cited by 13
“…no change in the number of DA neurones or striatal DA levels, slight mitochondrial and nigrostriatal neurotransmission deficits Kitada et al. (2007) Gautier et al. (2008) DJ-1 null KO Mouse DJ-1 knockout Mild deficits in DA neurotransmission, mitochondrial dysfunction, no loss of DA neuron Chen…”
Milk and Parkinson disease: Could galactose be the missing link
Sarni, A. R., & Baroni, L. (2018) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-180234 · Cited by 15
Rango, M., Arighi, A., Marotta, G., Ronchi, D., & Bresolin, N. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.10.004 · Cited by 12
The Role of Neuroinflammation in Parkinson's Disease
Chen, X., & Tansey, M. G. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-384913-7.00018-6 · Cited by 13
Role of rodent models in advancing precision medicine for Parkinson's disease
Simons, E., & Fleming, S. M. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00002-3 · Cited by 13
Vos, M. H., Verstreken, P., & Klein, C. (2015) · Biochemical Society Transactions · doi:10.1042/bst20140325 · Cited by 11
Gunn, T. M., Silvius, D., Lester, A., & Gibbs, B. (2019) · Mammalian Genome · doi:10.1007/s00335-019-09802-7 · Cited by 11
Baroli, B. M., Loi, E., Solari, P., Kasture, A. S., Moi, L., Muroni, P., Kasture, S. B., Setzu, M. D., Liscia, A. M., & Zavattari, P. (2019) · The FASEB Journal · doi:10.1096/fj.201901010 · Cited by 11
“Because mitochondria are a primary source of reactive oxygen species, PINK1 deficiency results in increased oxidative stress (33, 34).”
BackgroundDeciphering the dual role and prognostic potential of PINK1 across cancer types
Radin, D., Dai, K., & Leonardi, D. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.295314 · Cited by 13
“Several lines of evidence indicate that PINK1 confers protection against mitochondriadependent apoptosis induced by both intrinsic stress and environmental insults (Gautier et al., 2008; Wang et al., 2011a; Huang et al., 2016, 2017).”
BackgroundCharacterizing the role of the dark kinome in neurodegenerative disease – A mini review
Axtman, A. D. (2021) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2021.130014 · Cited by 13
Caffeine improves mitochondrial function in PINK1B9-null mutant Drosophila melanogaster
Gonçalves, D. F., Senger, L. R., Foletto, J. V. P., Michelotti, P., Soares, F. A. A., & Corte, C. L. D. (2022) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-022-09952-5 · Cited by 11
“Usually, the energy imbalance is a consequence of mitochondrial dysfunction, which is also a marker of this neurological disorder [2, 6, 7].”
BackgroundRat models of major neurodegenerative disorders
Novati, A., Singer, E., Yu-Taeger, L., Clemensson, E. K. H., & Nguyen, H. P. (2022) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2022.19 · Cited by 13
Oxidative Stress and Parkinson Disease
Lim, K., Graham, D. G., & Ng, X. (2011) · Wiley eBooks · doi:10.1002/9781118148143.ch10 · Cited by 11
Pearlstein, É., Michel, F. J., Save, L., Ferrari, D. C., & Hammond, C. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00168 · Cited by 11
“…an electrophysiological signature of dopamine depletion and PD, since they are reversed by chronic levodopa administration or subthalamic nucleus (STN) lesion used to treat PD (Kitada et al., 2007; Gautier et al., 2008; Dehorter et al., 2009, 2012; Gispert et al., 2009; Wang et al., 2011).”
BackgroundHomozygous CADPS2 Mutations Cause Neurodegenerative Disease with Lewy Body‐like Pathology in Parrots
Lorenzo‐Betancor, O., Galosi, L., Bonfili, L., Eleuteri, A. M., Cecarini, V., Verin, R., Dini, F., Attili, A., Berardi, S., Biagini, L., et al. (2022) · Movement Disorders · doi:10.1002/mds.29211 · Cited by 10
Metadata
- Authors
- Gautier, C. A., Kitada, T., & Shen, J.
- Affiliations
- Center for Neurologic Diseases, Brigham and Women's Hospital, Program in Neuroscience, Harvard Medical School, Boston, MA 02115
- Brigham and Women's Hospital (US)
- ORCID
- Shen, Jie
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-08-12
- Volume
- 105
- Issue
- 32
- Pages
- 11364-11369
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2516271
- OpenAlex
- W1990287702
- Cited by
- 698
- References
- 39
- Citations by year
- 2026: 18 · 2025: 18 · 2024: 24 · 2023: 29 · 2022: 37 · 2021: 32 · 2020: 48 · 2019: 30 · 2018: 36 · 2017: 33 · 2016: 49 · 2015: 37 · 2014: 46 · 2013: 45 · 2012: 53
- FWCI
- 34.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Massachusetts Institute of Technology
- National Institute of Neurological Disorders and Stroke (R01NS041779, R01 NS41779)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- PINK1, Parkinson's disease, mitochondrial dysfunction, mitochondrial respiration, oxidative stress, aconitase, striatum, cerebral cortex, nigrostriatal degeneration, dopaminergic neurons, aging, heat shock, hydrogen peroxide, TCA cycle
- MeSH terms
- PTEN-Induced Putative Kinase, Animals, Cerebral Cortex, Citric Acid Cycle, Corpus Striatum, Hydrogen Peroxide, Mitochondria, Oxygen Consumption, Parkinson Disease, Protein Kinases, Time Factors, Gene Deletion, Germ-Line Mutation, Mice, Knockout, Oxidative Stress, Heat-Shock Response, Mitochondrial Proteins, Mitochondrial Diseases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.